发明名称 |
Glycerophospholipids for the improvement of cognitive functions |
摘要 |
The invention described herein provides a preparation comprising a non-mammalian derived mixture of serine glycerophospholipid conjugates with a specific content and specific conjugation patterns of LA, linolenic acid (alpha-linolenic acid, gamma-linolenic acid) DHA and EPA which depend on utilizing different sources of lipids, and uses of such preparations. |
申请公布号 |
US9168310(B2) |
申请公布日期 |
2015.10.27 |
申请号 |
US201314063401 |
申请日期 |
2013.10.25 |
申请人 |
ENZYMOTEC LTD. |
发明人 |
Ben Dror Gai;Platt Dorit;Farkash Orly;Zuabi Rassan;Bar-On Zohar;Shulman Avidor;Pelled Dori;Richter Yael |
分类号 |
A23D9/013;A23L1/30;A61K31/66;A61K31/685;A61K47/48;C07F9/10;A21D2/32;A23D7/01 |
主分类号 |
A23D9/013 |
代理机构 |
Cooper & Dunham LLP |
代理人 |
White John P.;Cooper & Dunham LLP |
主权项 |
1. A method of improving a condition in an elderly subject with a disorder involving impaired cognitive performance which comprises administering to the subject an effective amount of a preparation comprising a non-mammalian derived mixture of serine glycerophospholipid conjugates, wherein the mixture comprises (a) linoleic acid (C18:2) conjugated to phosphatidylserine (PS), (b) docosahexaenoic acid (DHA) conjugated to PS, and (f) eicosapentaenoic acid (EPA) conjugated to PS, in which mixture the w/w % of (a)/the w/w % of (b) is from about 0.09 to about 3.6 and the w/w % of (a)/w/w % of (f) is from about 0.23 to about 9.4, and wherein the disorder is selected from the group consisting of cognitive impairment no dementia, pre-Alzheimer's disease, pre-dementia syndrome, age related cognitive decline, cognitive deterioration and any combination of two or more of such disorders. |
地址 |
Migdal Haemeq IL |